ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0377

Improving Self-Management Support in Patients with Juvenile Idiopathic Arthritis

Julia Harris1, Leslie Favier2, Emily Fox3, Michael Holland3, Cara Hoffart4, Maria Ibarra3, Jordan Jones4, Susan Parish2, Kara Remick-Erickson2 and Ashley Cooper4, 1Children's Mercy Kansas City, Overland Park, KS, 2Children's Mercy Kansas City, Kansas City, 3Children's Mercy Hospital, Kansas City, MO, 4Children's Mercy Kansas City, Kansas City, MO

Meeting: ACR Convergence 2024

Keywords: Juvenile idiopathic arthritis, Pediatric rheumatology, quality of care

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Self-management support (SMS) is one of the key elements of the Chronic Care Model as it is an important aspect of the care for patients with chronic conditions, including juvenile idiopathic arthritis (JIA). Patients with JIA and their families need to do many things to manage their disease including taking medications, getting infusions, obtaining frequent labs, attending rheumatology clinic visits, getting eye exams, and more. Through involvement with the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN), a North American learning health network, our site utilizes a barriers form to assess challenges in patients with JIA taking medications. We have several adherence tools that correspond to specific treatment barriers to provide patients and families and a Helping Hands handbook that provides additional resources. Despite having these resources, we only provided SMS to approximately 40% of patients with JIA in 2023. Our project aim was to increase the use of SMS from 40% to 75% by June 30, 2024. As the ultimate goal of SMS is to improve patient outcomes, we also aimed to increase the percent of patients with JIA in an inactive or low disease activity state by the 10-joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10) from 75% to 77.5% by June 30, 2024.

Methods: Our team utilized quality improvement methodology including use of a process map, fishbone diagram, failure modes and effects analysis, and plan-do-study-act cycles. Our outcome measure is the percent of patients with oligoarticular or polyarticular JIA who achieve inactive or low disease activity criteria by cJADAS10 at their last clinic visit. Our process measure is the percent of patients with JIA who have SMS provided in the past 180 days, which includes completion of a barriers assessment tool or receiving a Helping Hands handbook or an adherence solution tool. A balancing measure was the median time in clinic from time to seeing the physician until checkout. Interventions included physician and nurse education. A new JIA form in our electronic health record was also implemented and allowed for electronic capture of SMS. Nurses and physicians also utilized electronic adherence solution tools to attach to patient’s clinic depart paperwork. We evaluated our data on control charts to assess for special cause.

Results: Data was reviewed monthly starting in July 2022 for our outcome and process measures. Our outcome measure performance did not significantly change with the percent of patients with JIA meeting this measure definition in May 2024 at 76.7%. However, our process measure of providing SMS increased significantly. A shift in our data was present with the average performance now at 76% and May 2024 performance at 87% (Figure 1). Our balancing measure data over the past 12 months has not significantly changed with median time of patient in the clinic room of 49.5 minutes.   

Conclusion: Using quality improvement methodology, we were able to successfully increase the use of SMS for our patients with JIA and their families. We will continue to track this important process in our clinic in hopes to positively impact both disease activity and patient-reported outcomes in the future.

Supporting image 1

Figure 1. Annotated control chart of the percent of patients with JIA receiving self-management support. The black line indicates monthly data points. The blue line is the mean. The dashed lines are the upper and lower control limits.


Disclosures: J. Harris: None; L. Favier: None; E. Fox: None; M. Holland: None; C. Hoffart: None; M. Ibarra: None; J. Jones: None; S. Parish: None; K. Remick-Erickson: None; A. Cooper: None.

To cite this abstract in AMA style:

Harris J, Favier L, Fox E, Holland M, Hoffart C, Ibarra M, Jones J, Parish S, Remick-Erickson K, Cooper A. Improving Self-Management Support in Patients with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/improving-self-management-support-in-patients-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-self-management-support-in-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology